Correlation regression analysis was used to predict the outcome of acute urinary retention in benign prostatic hyperplasia

• 1. 尿TIMP-2和IGFBP-7在制备用于诊断脓毒症急性肾损伤的生物标记物中的用途 [P] . 中国专利： CN111413508A . 2020-07-14
• 2. 西洛司特在制备用于治疗急性肾损伤相关病症的药物中的用途 [P] . 中国专利： CN109908139B . 2022.02.22
• 3. METHOD FOR TREATING ACUTE URINARY RETENTION IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA [P] . UA35866U . 2008-10-10

  机译： 良性前列腺增生症患者急性尿RE留的治疗方法

• 4. PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA OR FOR THE LONG-TERM PREVENTION OF ACUTE URINARY RETENTION. [P] . ES2287474T3 . 2007-12-16

  机译： 药物组合治疗前列腺增生症或长期预防急性尿RE留。

• 5. PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA OR FOR THE LONG-TERM PREVENTION OF ACUTE URINARY RETENTION [P] . 欧洲知识产权局专利： EP1501517B1 . 2007-05-02

  机译： 药物组合治疗前列腺增生症或长期预防急性尿RE留

• 1. Correlation between Prostatic Calculi and Benign Prostatic Hyperplasia [J] . Ruipeng Tang, Chuan Xiao 内分泌系统研究(英文) . 2020,第001期
• 2. Clinical Nursing of Indwelling Catheter for Patients with Benign Prostatic Hyperplasia Complicated with Acute Urinary Retention [C] . Fanping Meng, Lina Zhou, Yuanyuan Zhao, Symposium on Health and Education . 2019
• 3. Multiscale image analysis of prostatic carcinoma and benign hyperplasia using confocal laser scanning microscope. [D] . Kim, Desok. 1993
• 4. Positive Predictive Value of Benign Prostatic Hyperplasia and Acute Urinary Retention in the Danish National Patient Registry: A Validation Study [O] . Maria Bisgaard Bengtsen, Uffe Heide-Jørgensen, Linea Sandfeld Blichert-Refsgaard, 2020
• 5. Abstract No. 60 Prostatic artery embolization with 100- to 300-μm microspheres to treat urinary retention attributable to benign prostatic hyperplasia: a single-center analysis of 4-year outcomes [O] . T. Powell, R. Ayyagari, L. Staib 2021

• 1. Association of Increased Urine Brain Derived Neurotrophic Factor with Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia [J] . Long-wang WANG ,Jian-long LI ,Yi YU . 华中科技大学学报（医学）（英德文版） . 2017,第004期
• 2. Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia? [J] . Li Tao Zhang ,Jong Kwan Park . 世界肾病学杂志：英文版 . 2015,第1期
• 3. An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction, and lower urinary tract symptoms secondary to benign prostatic hyperplasia [J] . Zhe Jin ,Zhi-Chao Zhang ,Ji-Hong Liu . 亚洲男性学杂志：英文版 . 2011,第4期
• 4. Effect of self-management on lower urinary tract symptoms and life quality of benign prostatic hyperplasia patients [J] . 陈晔 . 外科研究与新技术 . 2011,第4期
• 5. 尿L-FABP及其与尿NGAL联合应用在预测心脏手术后急性肾损伤中的价值 [C] . 刘上 ,车妙琳 ,谢波 . 中国中西医结合学会肾脏疾病专业委员会2011年学术年会暨2011年国际中西医结合肾脏病学术会议 . 2011
• 6. 良性前列腺增生症急性尿潴留相关因素分析 [A] . 战立龙 . 2010